Dave Ingamells has over 35 years of experience in CMC operations, including process development, bulk manufacturing, fill/finish, tableting, facilities design and construction, supply chain management, validation, metrology, quality assurance, and quality control. Products include clinical and commercial enzymes, antibodies, viral vectors, and antibiotics. Prior to Avid Bioservices, Dave was a CMC consultant, working for small emerging biotech companies. His most recent full-time role was vice president of manufacturing at Vaxart, Inc; in this position, he managed all CMC functions. Previously, he held positions at Optimer Pharmaceuticals (purchased by Merck), Molecular Medicine Bioservices (purchased by Millipore Sigma), BioMarin Pharmaceuticals, IDEC (merged with Biogen), and Genentech. He holds a BS in biochemistry from San Francisco State University.